Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET)

ClinicalTrials.gov ID: NCT03781791

Public ClinicalTrials.gov record NCT03781791. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 13, 2026, 3:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate Safety, Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease-Related Constipation (KARMET)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will be conducted as a multi-center, randomized, double-blind, placebo-controlled study. Approximately 72 patients will be randomized 3:1 to treatment or placebo, with approximately 54 patients allocated to receive the active investigational product and approximately 18 patients allocated to receive placebo. \- Study Update- Amendment 3 - In this amendment, an additional 80 patients (approximately) will be randomized 1:1 to treatment or placebo (double-blind) with approximately 40 subjects allocated to each group.

Study identification

NCT ID
NCT03781791
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Enterin Inc.
Industry
Enrollment
151 participants

Conditions and interventions

Eligibility (public fields only)

Age range
30 Years to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 9, 2018
Primary completion
Dec 13, 2021
Completion
Dec 13, 2021
Last update posted
Feb 19, 2024

2018 – 2021

United States locations

U.S. sites
51
U.S. states
26
U.S. cities
47
Facility City State ZIP Site status
Banner Sun Health Research Institute Sun City Arizona 85351
Clinical Trials, Inc. Little Rock Arkansas 72205
The Parkinson's and Movement Disorder Institute Fountain Valley California 92708
Neuro Pain Medical Center Fresno California 93710
Pacific Neuroscience Medical Group Oxnard California 93030
SC3 Research - Pasadena Pasadena California 91105
Trial Connections - Care Access Research, Santa Clarita Santa Clarita California 91321
Rocky Mountain Movement Disorders Center Englewood Colorado 80113
Associated Neurologist of Southern CT Fairfield Connecticut 06824
Care Access Research, Norwich Norwich Connecticut 06360
Georgetown University Hospital Washington D.C. District of Columbia 20007
JEM Research Institute Atlantis Florida 33462
Parkinson's Disease and Movement Disorders Center of Boca Raton Boca Raton Florida 33486
Elias Research - Floridian Research Institute Miami Florida 33145
Elias Research - Allied Biomedical Research Institute Miami Florida 33155
Pharmax Research of South Florida Miami Florida 33175
MEDSOL Clinical Research Port Charlotte Florida 33952
Parkinson's Disease Treatment Center of SWFL Port Charlotte Florida 33980
Intercoastal Medical Group Sarasota Florida 34239
University of South Florida Tampa Florida 33603
Palm Beach Neurology and Premier Research Institute West Palm Beach Florida 33407
Atlanta Center for Medical Research Atlanta Georgia 30331
BTC Network - Community Clinical Research Center Anderson Indiana 46011
Interspond - The Neuromedical Clinic of Central Louisiana Alexandria Louisiana 71301
The NeuroMedical Center, P.C. Baton Rouge Louisiana 70810
Parkinson's and Movement Disorders Center of Maryland Elkridge Maryland 21075
Henry Ford West Bloomfield Hospital West Bloomfield Michigan 48322
Neurology Associates Clinical Research Lincoln Nebraska 68506
Interspond - Neurology Center of Las Vegas Las Vegas Nevada 89128
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 13756
Evolution Research Group - Neuroscience Research Institution Toms River New Jersey 08755
Neuroscience Researc Institute of NJ Toms River New Jersey 08755
Albany Medical College Albany New York 12208
Icahn School of Medicine at Mount Sinai New York New York 10029
Raleigh Neurology Associates Raleigh North Carolina 27607
Wake Forest Baptist Medical Center Wake Forest North Carolina 27157
Dayton Center for Neurological Disorders Centerville Ohio 45459
University of Cincinnati Cincinnati Ohio 45219
Cleveland Clinic Cleveland Ohio 44095
Elias Research - Neurology Diagnostics Research Dayton Ohio 45459
University of Toledo Medical Center Toledo Ohio 43614
The Movement Disorder Clinic of Oklahoma Tulsa Oklahoma 74136
Penn State University Hershey Pennsylvania 17033
Interspond - Premier Neurology Greer South Carolina 29650
Interspond - Metrolina Neurological Associates Old Point Station South Carolina 29707
North Texas Movement Disorders Institute Bedford Texas 76021
BTC Network - Neurological Associates of North Texas Dallas Texas 75218
Clinical Trial Network Houston Texas 77074
Sentara Neuroscience Institute Norfolk Virginia 23456
Evergreen Health - Booth Gardner Parkinson's Care Center Kirkland Washington 98034
University Physicians & Surgeons, Inc. dba Marshall Health Huntington West Virginia 25701

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03781791, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 19, 2024 · Synced Sep 13, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03781791 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →